Mimicry between respiratory virus proteins and some human immune proteins
- Authors: Zhilinskaya I.N.1
-
Affiliations:
- Smorodintsev Institute of Influenza, Ministry of Health of the Russian Federation
- Issue: Vol 10, No 2 (2020)
- Pages: 305-314
- Section: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/2220-7619/article/view/118792
- DOI: https://doi.org/10.15789/2220-7619-MBR-1179
- ID: 118792
Cite item
Full Text
Abstract
Keywords
About the authors
I. N. Zhilinskaya
Smorodintsev Institute of Influenza, Ministry of Health of the Russian Federation
Author for correspondence.
Email: irina@influenza.spb.ru
Irina N. Zhilinskaya – PhD, MD (Biology), Leading Researcher, Laboratory of System Virology
197376, St. Petersburg, Prof. Popova str., 15/17
Phone: +7 (812) 499-15-71
References
- Canedo-Marroqu í n G., Acevedo-Acevedo O., Rey-Jurado E., Saavedra J.M., Lay M.K., Bueno S.M., Riedel C.A., Kalergis A.M. Modulation of host immunity by human respiratory syncytial virus virulence factors: a synergic inhibition of both innate and adaptive immunity. Front Cell Infect. Microbiol., 2017, vol. 7, pp. 367–380. doi: 10.3389/fcimb.2017.00367
- Dzananovic E., McKenna S.A, Patel T.R. Viral proteins targeting host protein kinase R to evade an innate immune response: a mini review. Biotechnol. Genet. Eng. Rev., 2018, vol. 34, no. 1, pp. 33–59. doi: 10.1080/02648725.2018.1467151
- Fonseca G.J., Thillainadesan G., Yousef A.F., Ablack J.N., Mossman K.L., Torchia J., Mymryk J.S., Adenovirus evasion of interferon-mediated innate immunity by direct antagonism of a cellular histone posttranslational modification. Cell Host Microbe, 2012, vol. 11, no. 6, pp. 597–606. doi: 10.1016/j.chom.2012.05.005
- Goritzka M., Pereira C., Makris S., Durant L.R., Johansson C. T cell responses are elicited against respiratory syncytial virus in the absence of signaling through TLRs, RLRs and IL-1R/IL-18R. Sci. Rep., 2015, vol. 5, pp. 18533–18550. doi: 10.1038/srep18533
- Griffin D.E., Plemper R.K. The immune response in measles: virus control, clearance and protective immunity. Viruses, 2016, vol. 8, no. 10, pp. 282–289. doi: 10.3390/v8100282
- Hendrickx R., Stichling N., Koelen J., Kuryk L., Lipiec A., Greber U.F. Innate immunity to adenovirus. Hum. Gene Ther., 2014, vol. 25, no. 4, pp. 265–284. doi: 10.1089/hum.2014.0
- Hulda R.J., Dijkman R. Coronaviruses and the human airway: a universal system for virus-host interaction studies. Front Microbiol., 2013, vol. 4, pp. 276–285. doi: 10.1186/s12985-016-0479-5
- Lecendreux M., Libri V., Jaussent I., Mottez E., Lopez R., Lavault S., Regnault A., Arnulf I., Dauvilliers Y. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination. J. Autoimmun., 2015, vol. 60, pp. 20–31. doi: 10.1016/j.jaut.2015.03.003
- Lei J., Hilgenfeld R. RNA-virus proteases counteracting host innate immunity. FEBS Lett., 2017, vol. 591, no. 20, pp. 3190–3210. doi: 10.1002/1873-3468.12827
- Li Y.H, Wei X., Ji S., Gui S.Y., Zhang S.M. In vivo effects of the NLRP1/NLRP3 inflammasome pathway on latent respiratory virus infection. Int. J. Mol. Med., 2018, vol. 41, no. 6, pp. 3620–3628. doi: 10.3892/ijmm.2018.3521
- Luo G., Ambati A., Lin L., Bonvalet M., Partinen M., Ji X., Maecker H.T., Mignot E.J. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc. Natl Acad. Sci. USA, 2018, vol. 115, no. 52, pp. E12323–E12332. doi: 10.1073/pnas.1818150116
- Matthews J.D., Tzeng W.P., Frey T.K. Determinants in the maturation of rubella virus p200 replicase polyprotein precursor. J. Virol., 2012, vol. 86, no. 12, pр. 6457–6469. doi: 10.1128/JVI.06132-11
- Newton A.H., Cardani A., Braciale T.J. The host immune response in respiratory virus infection: balancing virus clearance and immunopathology. Semin. Immunopathol., 2016, vol. 8, no. 4, pp. 471–482. doi: 10.1007/s00281-016-0558-0
- Rockx B., Donaldson E., Frieman M., Sheahan T., Corti D., Lanzavecchia A., Baric R.S. Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J. Infect. Dis., 2010, vol. 201, no. 6, pp. 946–955. doi: 10.1086/651022
- Saariaho A.H., Vuorela A., Freitag T.L., Pizza F., Plazzi G., Partinen M., Vaarala O., Meri S. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J. Autoimmun., 2015, vol. 63, pр. 68–75. doi: 10.1016/j.jaut.2015.07.006
- Sarkanen T.O., Alakuijala A.P.E., Dauvilliers .A., Partinen M.M. Incidence of narcolepsy after H1N1 influenza and vaccinations: Systematic review and meta-analysis. Sleep Med. Rev., 2018, vol. 38, pp. 177–186. doi: 10.1016/j.smrv.2017.06.006
- Totura A.L., Whitmore A., Agnihothram S., Schä fer A., Katze M.G., Heise M.T., Baric R.S. Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection. mBio, 2015, vol. 26, no. 3: e00638–15. doi: 10.1128/mBio.00638-15
- Voelker D.R., Numata M. Phospholipid regulation of innate immunity and respiratory viral infection. J. Biol. Chem., 2019, vol. 294, no. 12, pp. 4282–4289. doi: 10.1074/jbc.AW118.003229
- Walter J.M., Wunderink R.G. Severe respiratory viral infections: new evidence and changing paradigms. Infect. Dis. Clin. North Am., 2017, vol. 31, no. 3, pp. 455–474. doi: 10.1016/j.idc.2017.0
- Zhang L., Qin Y., Chen M. Viral strategies for triggering and manipulating mitophagy. Autophagy, 2018, vol. 14, no. 10, pp. 16651673. doi: 10.1080/15548627.2018.1466014
Supplementary files
